home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  October 18, 2021
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [7] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 466 active entries

Hubei Teyer Pharmaceutical Co.,Ltd.

161# Jieguan Road, Tianmen economy development zon
431700
China

Phone: 0086-728-5332568
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Stock symbol: Hubei Teye

Description:

Hubei Teyer Pharmaceutical Co., Ltd. was established in 2002, and is located in Tianmen, a historic city in Hubei Province, the former residence of Chinese "Tea Saint" Lu Yu.
 

Our company is committed to the production and distribution of Ganciclovir and other APIs advanced intermediates for about 20 years.
 

Teyer Pharmaceutical has developed a new synthesis process for Ganciclovir. , and we developed the groundbreaking research of synthesis process on Valganciclovir hydrochloride and obtained the invention patent certificate in 2017.
 

We are the first domestic manufacturer that successfully develop and produce the Monoacetylganciclovir, and our product lines also including the production of Diacetyl ganciclovir, Benzyl ganciclovir, CBZ-valganciclovir.

Hubei Teyer Pharmaceutical Co., Ltd  is a high-tech enterprise in Hubei Province. Our factory covers an area of 16,000 square meters. We own two GMP raw material synthesis workshops and a capsule tablet workshop, every workshop is strictly equipped with an independent clean and refining area.
 

We earnestly abide by the "Pharmaceutical Administration Law of the People's Republic of China" and organize production strictly conform to  the "Pharmaceutical Production Quality Management Regulations".


Relying on the concept of "Being authentic, Being driven "
and adhering to the inner core of "Life is to gain the true knowledge",
Teyer Pharmaceutical is defining ourselves in terms of customers and markers,we are acting entrepreneurially by seizing the moment.
 

There is a huge potential development of Teyer Pharmaceutical,
Our exclusive API production technology will help our partners to obtain excess profits and ensure the production market advantage when they apply it to the tablet or injection production.
 

After years of development, Teyer Pharmaceutical Co., Ltd. has become a special enterprise in China relying on its scientific management and strict production level.We will never forget the original intention and keep struggling to provide the best quality products and service to all of our customers.
 

Our belief is "to establish an image of integrity, to create a quality brand, to be market-oriented, and to seek development through innovation".

 

Sodium lauryl sulfoacetate SLSA exclusive supplier! 



Selected Categories:
Product Company   Service Company
Biotech
- General
Pharmaceutical
- General
- Research
Supplier
- General
Contract
- Production
- Research

Last update of this entry: September 28, 2021

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2021 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.